← Back to All Filings
UnitedHealth Group Director Receives Dividend Equivalent Shares
UNITEDHEALTH GROUP INC
$UNH4CIK: 0000731766
Subscribe to track UNH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Filing: UNITEDHEALTH GROUP INC ($UNH)
**Insider:** John H. Noseworthy
**Role:** Director
**Transaction Date:** 2026-09-22
**Filing Date:** 2026-09-24
### Transaction Details
- **Type:** Grant / Dividend Equivalent (Code A)
- **Shares Acquired:** 46
- **Price:** $0.00
- **Total Value:** $0.00
- **Post-Transaction Holdings:** 7,662 shares (Direct)
**Significance:** Low (Routine dividend equivalent reinvestment on deferred stock units)
Comprehensive Analysis
Executive Summary
On September 24, 2026, a Form 4 was filed for UNITEDHEALTH GROUP INC ($UNH) on behalf of Director John H. Noseworthy, M.D. The filing documents the acquisition of 46 shares of Common Stock on September 22, 2026 at an acquisition price of $0.00 per share.
Transaction Mechanics & Context
- Transaction Nature: The reported transaction is coded as
A(Grant, award, or other acquisition). Footnote 1 clarifies that these shares represent dividend equivalents credited on vested deferred stock units. The dividend equivalents vest immediately and carry the same terms as the underlying units. - Significance Level: Low. The transaction does not reflect an open-market purchase or sale, but rather an automatic, routine crediting of dividend equivalents on existing equity awards.
- Ownership Breakdown: Following the transaction, Dr. Noseworthy directly holds 7,662 shares of UnitedHealth Group Common Stock.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.